C021 Post hoc Analysis: Effects of Reducing Lamotrigine or Carbamazepine Dose in Patients With Uncontrolled Focal Seizures Receiving Cenobamate

April 17 – 22, 2021; Virtual Meeting
Analysis of seizure-free patients suggests dose of ASMs may be able to be reduced while receiving concomitant cenobamate, without compromising long-term efficacy.
Format: Microsoft PowerPoint (.ppt)
File Size: 495 KB
Released: April 26, 2021


Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from
Greenwich Biosciences, Inc.

Related Content

From CCO: Companion Migraine Comorbidities slideset with highlights from Do-It-Better RealCME on Improving Migraine Treatment, and Prevention.

Jessica Ailani, MD Released: June 25, 2020

From CCO: companion migraine prophylaxis slideset with highlights from Do-It-Better RealCME on improving migraine treatment, and prevention

Wade Cooper, DO Released: June 25, 2020

Expert-authored slideset with latest data on migraine prophylaxis using CGRP-targeting monoclonal antibodies, gepants, ditans, and tritans, from CCO.

Wade Cooper, DO Merle Diamond, MD Released: February 14, 2020

Faculty respond to frequently asked questions on diagnosing and managing progressive MS.

Released: December 4, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.